Paolo Cianciulli

Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial

Aurelio Maggio, Gennaro D’Amico, Alberto Morabito et al. · Blood Cells Molecules and Diseases · 2002 · 190 citations

Medicine, Hematology, Pharmacology +8

Hepatocellular carcinoma in the thalassaemia syndromes

Caterina Borgna‐Pignatti, Gianluca Vergine, T. Lombardo et al. · British Journal of Haematology · 2003 · 175 citations

Medicine, Hematology, Oncology +17

Multicenter validation of the magnetic resonance t2* technique for segmental and global quantification of myocardial iron

Anna Ramazzotti, Alessia Pepe, Vincenzo Positano et al. · Journal of Magnetic Resonance Imaging · 2009 · 147 citations · Full text

Medicine, Radiology, Diagnostic Imaging +15

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · Journal of Cardiovascular Magnetic Resonance · 2013 · 138 citations · Full text

Medicine, Cardiology, Pharmacology +16

Improved T2* assessment in liver iron overload by magnetic resonance imaging

Vincenzo Positano, Benedetta Salani, Alessia Pepe et al. · Magnetic Resonance Imaging · 2008 · 136 citations

Medicine, Radiology, Diagnostic Imaging +13